Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 57

1.

National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease.

NACB LMPG Committee Members, Myers GL, Christenson RH, Cushman M, Ballantyne CM, Cooper GR, Pfeiffer CM, Grundy SM, Labarthe DR, Levy D, Rifai N, Wilson PW.

Clin Chem. 2009 Feb;55(2):378-84. doi: 10.1373/clinchem.2008.115899. Epub 2008 Dec 23.

PMID:
19106185
[PubMed - indexed for MEDLINE]
Free Article
2.

Guidelines on cardiovascular disease prevention in clinical practice: the European perspective.

Graham IM.

Curr Opin Cardiol. 2005 Sep;20(5):430-9. Review.

PMID:
16093763
[PubMed - indexed for MEDLINE]
3.

Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice.

Vittorini S, Clerico A.

Clin Chem Lab Med. 2008;46(6):748-63. doi: 10.1515/CCLM.2008.188. Review.

PMID:
18601595
[PubMed - indexed for MEDLINE]
4.

Biomarkers for cardiovascular disease: challenges and future directions.

May A, Wang TJ.

Trends Mol Med. 2008 Jun;14(6):261-7. doi: 10.1016/j.molmed.2008.04.003. Epub 2008 May 16. Review.

PMID:
18487087
[PubMed - indexed for MEDLINE]
5.

The emerging risk factors for cardiovascular disease: a review of the epidemiologic evidence for lipoprotein(a), homocysteine, and fibrinogen.

Catena C, Cavarape A, Dotto L, Colussi G, Novehllo M, De Marchi S, Sechi LA.

Adv Clin Path. 2003 Jan;7(1):3-11. Review.

PMID:
19774732
[PubMed - indexed for MEDLINE]
6.

Identifying novel biomarkers for cardiovascular disease risk prediction.

Ge Y, Wang TJ.

J Intern Med. 2012 Nov;272(5):430-9. doi: 10.1111/j.1365-2796.2012.02589.x. Epub 2012 Oct 15. Review.

PMID:
22950687
[PubMed - indexed for MEDLINE]
7.

[What are the biomarkers of atherosclerosis and cardiovascular risk?].

Riesen WF.

Rev Med Suisse. 2008 Mar 12;4(148):636-8, 640-3. Review. French.

PMID:
18459658
[PubMed - indexed for MEDLINE]
8.

Candidate circulating biomarkers for the cardiovascular disease continuum.

Dotsenko O, Chackathayil J, Patel JV, Gill PS, Lip GY.

Curr Pharm Des. 2008;14(24):2445-61. Review.

PMID:
18781994
[PubMed - indexed for MEDLINE]
9.

Risk stratification in cardiovascular disease primary prevention - scoring systems, novel markers, and imaging techniques.

Zannad F, De Backer G, Graham I, Lorenz M, Mancia G, Morrow DA, Reiner Z, Koenig W, Dallongeville J, Macfadyen RJ, Ruilope LM, Wilhelmsen L; ESC Working Group on CardioVascular Pharmacology and Drug Therapy.

Fundam Clin Pharmacol. 2012 Apr;26(2):163-74. doi: 10.1111/j.1472-8206.2011.01023.x. Epub 2012 Jan 5. Review.

PMID:
22220636
[PubMed - indexed for MEDLINE]
10.

[Predictive value of human genotoxicological biomarkers in the primary prevention of chronic non-infectious diseases].

Tompa A.

Magy Onkol. 2004;48(2):117-20. Epub 2004 Sep 7. Review. Hungarian.

PMID:
15351804
[PubMed - indexed for MEDLINE]
Free Article
11.

[Prognostic value and clinical effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac events].

Schwarzer R, Schnell-Inderst P, Grabein K, Göhler A, Stollenwerk B, Grandi N, Klauss V, Wasem J, Siebert U.

Z Evid Fortbild Qual Gesundhwes. 2009;103(6):319-29. Review. German.

PMID:
19839204
[PubMed - indexed for MEDLINE]
12.

Biomarkers and cardiovascular risk assessment for primary prevention: an update.

Gilstrap LG, Wang TJ.

Clin Chem. 2012 Jan;58(1):72-82. doi: 10.1373/clinchem.2011.165712. Epub 2011 Nov 28. Review.

PMID:
22125305
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Clinical laboratory findings associated with in-hospital mortality.

ten Boekel E, Vroonhof K, Huisman A, van Kampen C, de Kieviet W.

Clin Chim Acta. 2006 Oct;372(1-2):1-13. Epub 2006 May 12. Review.

PMID:
16697361
[PubMed - indexed for MEDLINE]
14.

Surrogate endpoints and emerging surrogate endpoints for risk reduction of cardiovascular disease.

Rasnake CM, Trumbo PR, Heinonen TM.

Nutr Rev. 2008 Feb;66(2):76-81. doi: 10.1111/j.1753-4887.2007.00010.x. Review.

PMID:
18254873
[PubMed - indexed for MEDLINE]
15.

Biomarkers in acute cardiac disease: the present and the future.

Jaffe AS, Babuin L, Apple FS.

J Am Coll Cardiol. 2006 Jul 4;48(1):1-11. Epub 2006 Jun 12. Review.

PMID:
16814641
[PubMed - indexed for MEDLINE]
Free Article
16.

A review of lipid management in primary and secondary prevention.

Dembowski E, Davidson MH.

J Cardiopulm Rehabil Prev. 2009 Jan-Feb;29(1):2-12. doi: 10.1097/HCR.0b013e318192754e. Review.

PMID:
19158581
[PubMed - indexed for MEDLINE]
17.

Biomarkers in cardiovascular medicine.

Martín-Ventura JL, Blanco-Colio LM, Tuñón J, Muñoz-García B, Madrigal-Matute J, Moreno JA, Vega de Céniga M, Egido J.

Rev Esp Cardiol. 2009 Jun;62(6):677-88. Review. English, Spanish.

PMID:
19480764
[PubMed - indexed for MEDLINE]
Free Article
18.

[New biomarkers for cardiovascular risk evaluation].

Chironi G.

Rev Prat. 2012 Jun;62(6):783-5. Review. French.

PMID:
22838270
[PubMed - indexed for MEDLINE]
19.

The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.

Kones R.

Ther Adv Cardiovasc Dis. 2009 Aug;3(4):309-15. doi: 10.1177/1753944709337056. Epub 2009 May 21. Review.

PMID:
19460829
[PubMed - indexed for MEDLINE]
20.

Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force.

Helfand M, Buckley DI, Freeman M, Fu R, Rogers K, Fleming C, Humphrey LL.

Ann Intern Med. 2009 Oct 6;151(7):496-507. Review.

PMID:
19805772
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk